4.8 Article

Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms

Journal

ACS NANO
Volume 16, Issue 5, Pages 7309-7322

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.1c06258

Keywords

peptide amphiphile; abdominal aortic aneurysm; targeted nanomaterials; matrix metalloproteinases; self-assembly

Funding

  1. University of North Carolina School of Medicine
  2. American Australian Association Fellowship
  3. Center for Regenerative Nanomedicine at the Simpson Querrey Institute for BioNanotechnology at Northwestern University
  4. National Institutes of Health [(5R0)-ES031635]
  5. Cancer Center Core Support Grant [P30 CA016086]
  6. North Carolina Biotech Center Institutional Support Grant [2016-IDG-1016]
  7. National Cancer Institute of the National Institutes of Health [P30CA016086]
  8. Northwestern University
  9. E.I. DuPont de Nemours Co.
  10. Dow Chemical Company
  11. U.S. DOE [DE-AC02-06CH11357]
  12. U.S. Army Research Office
  13. U.S. Army Medical Research and Materiel Command
  14. Soft and Hybrid Nanotechnology Experimental (SHyNE) [NSF ECCS-2025633]

Ask authors/readers for more resources

This study reports the development of injectable supramolecular nanofibers that target fragmented elastin, matrix metalloproteinase 2, and membrane type 1 matrix metalloproteinase to reduce the risks associated with a ruptured abdominal aortic aneurysm. The results show that one of the nanofibers was able to better localize to the aneurysm tissue and had an optimal dose.
An abdominal aortic aneurysm (AAA) is a localized dilation of the aorta located in the abdomen that poses a severe risk of death when ruptured. The cause of AAA is not fully understood, but degradation of medial elastin due to elastolytic matrix metalloproteinases is a key step leading to aortic dilation. Current therapeutic interventions are limited to surgical repair to prevent catastrophic rupture. Here, we report the development of injectable supramolecular nanofibers using peptide amphiphile molecules designed to localize to AAA by targeting fragmented elastin, matrix metalloproteinase 2 (MMP-2), and membrane type 1 matrix metalloproteinase. We designed four targeting peptide sequences from X-ray crystallographic data and incorporated them into PA molecules via solid phase peptide synthesis. After coassembling targeted and diluent PAs at different molar ratios, we assessed their ability to form nanofibers using transmission electron microscopy and to localize to AAA in male and female Sprague-Dawley rats using light sheet fluorescence microscopy. We found that three formulations of the PA nanofibers were able to localize to AAA tissue, but the MMP-2 targeting PA substantially outperformed the other nanofibers. Additionally, we demonstrated that the MMP-2 targeting PA nanofibers had an optimal dose of 5 mg (similar to 12 mg/kg). Our results show that there was not a significant difference in targeting between male and female Sprague-Dawley rats. Given the ability of the MMP-2 targeting PA nanofiber to localize to AAA tissue, future studies will investigate potential diagnostic and targeted drug delivery applications for AAA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available